Valuation: CEREP

Market Cap 91.8M 106M 86.63M 78.59M 147M 10.15B 149M 1.03B 399M 5.15B 398M 389M 16.38B P/E 2024 *
-
P/E 2025 -
Enterprise Value 70.77M 81.67M 66.78M 60.59M 114M 7.83B 114M 798M 307M 3.97B 307M 300M 12.62B EV / Sales 2024
2.02x
EV / Sales 2025 1.67x
Free-Float
4.22%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 2024-04-10
Director TitleAgeSince
Chairman - 2023-08-10
Director/Board Member - 2024-05-22
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+0.56%-5.82%-2.45%+9.99% 45.48B
+0.60%-1.05%+344.05%+530.26% 43.68B
+1.52%+2.43%+42.77%+24.68% 43.09B
+2.14%+0.85%+6.68%+78.57% 39.4B
+0.34%-4.94%+9.34%+40.23% 31.91B
+0.52%-3.13% - - 17.31B
+0.96%+0.50%+19.63%+112.07% 16.4B
+2.07%-0.77%+13.07%+32.89% 14.24B
-1.98%-3.24%+78.44%+30.75% 13.28B
Average +0.64%-2.97%+63.94%+107.43% 29.42B
Weighted average by Cap. +0.91%-3.26%+76.25%+128.38%

Financials

2024 2025
Net sales 40.49M 46.73M 38.21M 34.66M 65.02M 4.48B 65.5M 456M 176M 2.27B 175M 172M 7.22B 41.1M 47.43M 38.79M 35.19M 66.01M 4.55B 66.48M 463M 178M 2.31B 178M 174M 7.33B
Net income 7.15M 8.26M 6.75M 6.13M 11.49M 791M 11.57M 80.64M 31.07M 401M 31.01M 30.33M 1.28B 4.78M 5.52M 4.51M 4.09M 7.68M 529M 7.74M 53.9M 20.77M 268M 20.73M 20.27M 853M
Net Debt -17.25M -19.91M -16.28M -14.77M -27.71M -1.91B -27.91M -194M -74.93M -968M -74.78M -73.14M -3.08B -21.03M -24.28M -19.85M -18.01M -33.78M -2.33B -34.03M -237M -91.35M -1.18B -91.18M -89.17M -3.75B
Logo CEREP
Eurofins Cerep specializes in the pre-clinical research of drugs for the pharmaceutical industry. Export accounts for 88.2% of net sales.
Employees
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!